お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
925218

世界の骨移植・骨代用材市場:成長、動向、および予測

Bone Grafts and Substitutes Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
世界の骨移植・骨代用材市場:成長、動向、および予測
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界の骨移植・骨代用材市場について調査しており、市場機会や動向、成長および阻害要因、製品・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 交通事故や関節疾患の増加
    • 生体適合性合成骨移植片の開発
    • 歯科用骨移植片の需要増加
  • 市場阻害要因
    • 手術の高いコスト
    • 骨移植に関連する倫理的問題
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • 同種移植片
    • 骨代用材
    • その他
  • 用途別
    • 頭蓋顎顔面
    • 歯科
    • 関節再建
    • 脊椎固定術
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Zimmer Biomet
    • Stryker Corporation
    • Smith & Nephew PLC
    • Medtronic PLC
    • Johnson and Johnson
    • Baxter International Inc.
    • Integra Lifesciences Holdings Corporation
    • Orthofix Holdings Inc.
    • Geistlich Pharma AG
    • SeaSpine

第7章 市場機会および今後の動向

目次
Product Code: 57292

The major factors driving the growth of the market studied include the rising number of road injuries and joint disorders. There are various bone and joint disorders affecting the body's musculoskeletal system, which include arthritis, osteoarthritis, rheumatoid arthritis, osteoporosis, and fractures. Arthritis is the leading cause of disability among adults in the United States. Almost 50 million people in the United States experience some type of arthritis.

According to the data from the World Population Prospects: The 2017 Revision, the number of older people (those aged 60 years or above) is expected to more than double by 2050, rising from 962 million in 2017 to 2.1 billion in 2050, and 3.1 billion in 2100. Globally, the population aged 60 years or above is registering faster growth than all younger age groups. The aging populace is more prone to musculoskeletal disorders, such as arthritis and osteoporosis. According to the State of Musculoskeletal Health 2019 report, in the United Kingdom, around 8.75 million people aged between 45 years and over (33%) sought treatment for osteoarthritis. The knee is the most common site in the body for osteoarthritis, followed by the hip and hands/wrists.

Hence, due to the growing burden of joint disorders, there is an increasing demand for the bone graft and substitutes.

Key Market Trends

Joint Reconstruction Area of Application is Poised to Grow Rapidly Over the Forecast Period

The major factors expected to drive the growth of the market studied are the rising number of cases of joint disorders and the increasing number of surgeries across the world. Joint reconstruction is a surgery performed for reconstructing the architecture of a joint for restoring its functions. Some of the joint reconstruction procedures are found to be the total hip replacement, total knee replacement, and the anterior cruciate ligament.

As per the NIH, it is expected that, by the end of 2030, around 67 million people may be suffering from osteoarthritis in the United States. This, in turn, is expected to increase the adoption of joint reconstruction. Furthermore, according to the National Joint Registry in 2017, it was estimated that approximately 160,000 total hip and knee replacement procedures are performed each year, in England and Wales. The American Academy of Orthopaedic Surgeons (AAOS), in 2015, estimated that knee and hip replacement dominated the joint replacement procedures. Hence, with the aforementioned statistics, it is evident that an increasing number of replacement surgeries are taking place across the world, with the increasing usage of bone grafts and substitutes.

United States Holds the Largest Share of Market Studied

The United States accounts for a major share in the market studied, owing to the increasing incidences of sports injuries, joint disorders, rapid adoption of advanced technology, and improved healthcare system, along with the reimbursement scenario. According to the US Arthritis Foundation, arthritis is the leading cause of disability among adults in the country. By conservative estimates, about 54 million adults have been diagnosed with arthritis and almost 300,000 children have been suffering from arthritis or a rheumatic condition.

Thus, considering the rising incidences of joint disorders and increasing technological advancements, the US bone grafts and substitutes market is expected to grow rapidly over the forecast period.

Competitive Landscape

The market studied is moderately competitive and several local, as well as international companies, are present in the market. There is a rising technological development in the field of bone grafts and substitutes. For instance, in January 2019, one of the market players, Bioventus, announced the launch of OSTEOMATRIX+, its next-generation biphasic bone graft for use in bone remodeling in a variety of orthopedic and spine applications.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Road Injuries and Joint Disorders
    • 4.2.2 Development of Biocompatible Synthetic Bone Grafts
    • 4.2.3 Increase in the Demand for Dental Bone Grafts
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgeries
    • 4.3.2 Ethical Issues Related to Bone Grafting
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Allografts
    • 5.1.2 Bone Graft Substitutes
    • 5.1.3 Other Products
  • 5.2 By Application
    • 5.2.1 Craniomaxillofacial
    • 5.2.2 Dental
    • 5.2.3 Joint Reconstruction
    • 5.2.4 Spinal Fusion
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zimmer Biomet
    • 6.1.2 Stryker Corporation
    • 6.1.3 Smith & Nephew PLC
    • 6.1.4 Medtronic PLC
    • 6.1.5 Johnson and Johnson
    • 6.1.6 Baxter International Inc.
    • 6.1.7 Integra Lifesciences Holdings Corporation
    • 6.1.8 Orthofix Holdings Inc.
    • 6.1.9 Geistlich Pharma AG
    • 6.1.10 SeaSpine

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.